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A B S T R A C T
Population based studies suggest that symptoms of depression and anxiety are more frequent in children
and adolescents with epilepsy compared with the general population. In terms of the manifestations of
symptoms of depression and anxiety, there would appear to some symptoms unique to epilepsy in that
they are associated with seizures and/or antiepileptic medications but these idiosyncratic symptoms
remain under reported and have not been extensively studied. In terms of correlates of signiﬁcant
symptoms of depression and anxiety in children with epilepsy, some reports indicate that seizure
variables (e.g., seizure frequency) and use of polytherapy are associated with increases in symptoms
whereas other studies have not found this relationship. Child and family attitude/adaptation to epilepsy
may also be risk factors for depression and anxiety but more research is needed in this area. The
assessment of symptoms of depression and anxiety in children with epilepsy can be challenging given
the possible role of seizures and AEDs, and comprehensive assessment will involve the use of screening
measures, diagnostic interviews and a consideration of epilepsy speciﬁc factors. There have been few
studies carried out with respect to the treatment of symptoms and depression and anxiety in children
and adolescents with epilepsy. There is a signiﬁcant need for a greater understanding of the nature of
symptoms of depression and anxiety in children with epilepsy to inform treatment decisions. While
treatment of epilepsy speciﬁc symptoms of depression and anxiety may involve an evaluation of the
current epilepsy treatment protocols, there may also be a need for pharmacological and/or
psychotherapeutic interventions in the treatment of symptoms of depression and anxiety which are
not epilepsy speciﬁc.
 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Children with epilepsy have been reported to be at high risk for
behavioural and psychiatric disorders in population based
studies.1,2 Elevated rates of depression, anxiety and suicidal
attempts have been reported in adults with epilepsy3–6 and it is
increasingly being realised that both depression and anxiety in
youth with epilepsy are common but often unrecognized
disorders.7,8 Therefore, the early identiﬁcation and treatment of
both conditions is crucial to minimize the risk for suicide and
negative impact on quality of life. The reported frequency and
severity of emotional and behavioural problems in children with
epilepsy would suggest that a comprehensive epilepsy service
should provide assessment and treatment of psychiatric problems9
and there should be regular monitoring of psychological adjust-
ment of children with epilepsy.2 However, such difﬁculties are
often either unrecognized or assessment and intervention are not* Corresponding author. Tel.: +44 01342 832243.
E-mail address: colin.reilly@ucdconnect.ie (C. Reilly).
1059-1311/$ – see front matter  2011 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2011.06.004available. Ott et al.10 reported that although 60% of children with
epilepsy in a clinic based study met criteria for one or more
psychiatric diagnoses, nearly two-thirds of those with one or more
diagnoses were not in receipt of treatment for the conditions.
The fourth edition (text revised) of the Diagnostic and Statistical
Manual of Mental Disorders (DSM-IV-TR)11 classiﬁes mood
disorders into depressive disorders including major depressive
disorder (MDD), dysthymic disorder, and depressive disorder NOS
(not otherwise speciﬁed), and bipolar disorders. In studies of
children with epilepsy distinctions between different types of
depressive disorders have not usually been made and bipolar
disorders have not been widely studied. The essential feature of a
major depressive episode is a period of at least two weeks in which
there is either low mood or loss of interest/pleasure in most
activities and in children and adolescents the mood may be
irritable as opposed to sad.11 Other possible symptoms include
changes in appetite or weight, sleep and psychomotor activity,
decreased energy, feelings of worthlessness or guilt, difﬁculty
thinking, concentrating or making decisions or recurrent thoughts
of death or suicidal ideation, plans or attempts.11 The point
prevalence of depression in children is 1–2%, increasing to 3–8% invier Ltd. All rights reserved.
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adolescents will have experienced at least one depressive
episode.12
While the focus has often been on depression in individuals
with epilepsy, symptoms of anxiety and anxiety disorders may be
just as common and disabling.13 The DSM-IV-TR classiﬁes anxiety
into several types, including panic disorder, obsessive-compulsive
disorder (OCD), agoraphobia, social phobia, speciﬁc phobia, post-
traumatic stress disorder (PTSD), and generalized anxiety disorder
(GAD). Again distinctions between different types of anxiety
disorder have not usually been made in studies of children with
epilepsy. In the paediatric population, anxiety disorders affect 5–
18% of children, 0.3–12.9% of preadolescents, and 0.6–7% of
adolescents.14 In individuals without epilepsy depressive and
anxiety disorders tend to occur together with a high frequency, and
anxiety is often co morbid with depression in epilepsy.15,16
Therefore, for the purposes of this review article depression and
anxiety are discussed together although where differences exist
they will be discussed separately.
2. Methodology
In order to identify appropriate studies and reviews/position
papers for inclusion a literature search was undertaken in March
2011 using the electronic databases PubMed and PsychINFO. The
search was conducted using the using the following keywords in
‘title’: epilepsy + depression + children/adolescents, and epilep-
sy + anxiety + children/adolescents as illustrated in Fig. 1. The
original search yielded 24 unique papers. To meet criteria for
inclusion in this review a study or review position/paper had to: (1)
be written in English, (2) report on the prevalence and/or riskEpilepsy + Children  + Anxiety  (10) 
Epilepsy + Adolescents + Anxiety ( 2)
Epile
Epilep
Articles focu sing  on  depressi 
children/adolescents with ep 
Relevant articles 
Relevant articles  (4
Fig. 1. Search process in identifyfactors for symptoms of depression/anxiety in children/adoles-
cents (0–18 years) with epilepsy, (3) report on the treatment of
depression/anxiety in children/adolescents with epilepsy, (4)
review the literature or put forward a view/position on depres-
sion/anxiety in children/adolescents with epilepsy. The objectives
of the review were to review papers focussing on the prevalence
and correlates of depression and/or anxiety in childhood epilepsy
and to examine issues with regard to manifestation of symptoms,
assessment of such symptoms and intervention/treatment in this
population.
Sixteen papers met inclusion criteria after the initial search. Of
these 16, nine papers focussed primarily on the prevalence of and/
or risks for depression/anxiety in children/adolescents with
epilepsy, four were reviews/position papers on depression/anxiety
in children/adolescents with epilepsy, two focussed on treatment
of depression/anxiety in children/adolescents with epilepsy, and
one paper focussed on academic achievement in children/
adolescents with epilepsy and depression. Excluded papers
included articles focussed on depression/anxiety in parents of
children with epilepsy, siblings of children with epilepsy, and
studies published in languages other than English.
None of the 16 studies included population based data on the
prevalence of depression/anxiety in children/adolescents with
epilepsy. In order to identify population based studies and further
pertinent studies the following epilepsy/neurology journals were
electronically searched using the terms ‘depression’ and ‘anxiety’:
Developmental Medicine and Child Neurology, Epilepsia, Epilepsy &
Behavior, Epilepsy Research, Seizure, and Journal of Child Neurology.
Reference lists from already included articles and articles identiﬁed
via the journal based search were also used to identify relevant
papers. Six population based studies and one meta-analysis ofpsy + Children  + Depression  (14) 
sy + Adolescents +  Depression  (11) 
on/anxiety in 
ilepsy (24) 
 (16) 
Population b ased studies of ps ychopat hology in 
children/adolescents with  epileps y (6) 
Clinic  based  studies  of  depression/anxiety  in 
children/adolescents with  epileps y (8) 
Cli nic  based studie s of  psychopatho logy in 
children/adolescents with epileps y (11) 
Meta-Analysis of p sychop atholo gy i n 
children/adolescents with  epileps y (1) 
Reviews/position papers on  depression/anxiety  in 
children/adolescents with  epileps y (7) 
9) 
Not written in English (3) 
Depr ess ion/anxie ty in siblings  (1 ) 
Depression/anxiety in parents  (4) 
ing articles for the review.
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anxiety and/or depression were found and eight clinic based studies
of children with epilepsy which included speciﬁc measures of
depression and/or anxiety were identiﬁed. Eleven studies focussing
on psychopathology in children with epilepsy which included
measures of depression/anxiety were found. A further seven review/
position papers focussing wholly or partially on depression/anxiety
in children/adolescents with epilepsy were also identiﬁed via this
secondary search. A total of 49 papers were identiﬁed for the
purposes of the review. Studies involving measures of psychopa-
thology in children with epilepsy which did not include speciﬁc
measures of depression and/or anxiety were not reviewed.
3. Prevalence rates of depression and anxiety in children with
epilepsy
Population based studies are important with regard to
identifying prevalence rates of psychiatric disorders in children
with epilepsy, as epilepsy is characterised by a spectrum of
severity. Reported rates of psychopathology from specialised
epilepsy clinics will be higher than rates from population samples
as these clinics tend to treat children from the more severe or
complex end of the epilepsy spectrum.17 Two population based
studies included children with intellectual disability and epilepsy
and these studies are referred to in the section on childhood
epilepsy and intellectual disability.18,19 Table 1 illustrates the four
identiﬁed population based studies that have focussed on
psychopathology in children with epilepsy and included measures
of either depression and/or anxiety.
The differences in reported prevalence rates of anxiety and
depression in the population based studies are likely to be
reﬂective of both the criteria used to identify/diagnose children
with depression and/or anxiety and also how children with
epilepsy were ascertained. In only two of the studies2,20 were DSM-
IV21 criteria used to identify depression and/or anxiety. Davies
et al.2 used the term ‘emotional disorder’ as a proxy for depression
and/or anxiety and did not report separate rates for both disorders
while Hedderick and Buchhalter20 used the term ‘mood disorder’
presumably to denote depressive disorders. Regarding the
identiﬁcation of epilepsy, in the Davies et al.2 and McDermott
et al.22 studies parents were asked to indicate whether their childTable 1
Population-based studies of depression/anxiety in children with epilepsy.
References Location Sample source Age of sample S
si
Berg et al.23 USA Connecticut Study
of Epilepsy
5.9 + 9 yearsa 5
Davies et al.2 UK British child and
adolescent mental
health survey
5–15 years 
Hedderick and
Buchhalter20
USA Rochester epidemiology
project
<16 years of age 1
McDermott et al.22 USA Data from national health
interview survey
5–17 years 1
DAWBA, Development and Well-Being Assessment24; BPI, Behaviour Problem Index25;
a Children originally diagnosed at an average age of 5.9 years and followed up 9 yeahad epilepsy. In the Berg et al.23 study which had the largest
number of participants, the children/adolescents had been
participating in the Connecticut Study of Epilepsy a longitudinal
study of children recruited from the ofﬁces of paediatric
neurologists in Connecticut. Hedderick and Buchhalter20 used
data from the Rochester Epidemiology project based on all incident
cases of epilepsy diagnosed in the Rochester area over a 15-year
period. Davies et al.2 and McDermott et al.22 were able to use
comparison data from control children with other health condi-
tions and control children from the general paediatric population,
to show that the prevalence of difﬁculties with depression and/or
anxiety were signiﬁcantly higher in children with epilepsy
compared with both types of controls. Davis et al.2 reported that
rates of ‘emotional disorder’ for children with ‘complicated
epilepsy’ were similar to rates for those with ‘uncomplicated
epilepsy’ suggesting that difﬁculties with anxiety and depression
are not restricted to children with epilepsy who have additional
neurological or intellectual difﬁculties. ‘Complicated epilepsy’
included children with severe learning difﬁculties (vocabulary
quotient <60), speech or language difﬁculties, cerebral palsy, other
physical impairments, and congenital conditions.2
Studies of prevalence rates of depression and/or anxiety for
children with epilepsy drawn from clinic based samples have
reported rates of depression and/or anxiety with respect to norms
on standardised behavioural checklists and/or comparisons with
mean scores of children acting as controls. In the majority of clinic
based studies children with epilepsy who are functioning in the
intellectually disabled range have been excluded. In a meta-
analysis of studies of psychopathology in children with epilepsy
Rodenburg et al.26 reported that children with epilepsy were more
likely to have difﬁculties with ‘anxious/depressed’ domains on
checklists (mainly the CBCL)27 compared with normative controls
via parent report, teacher report and self-report. Children with
epilepsy were also likely to have difﬁculties with ‘anxious/
depressed’ domains compared with healthy study controls on
parent report, and children with another chronic illness on parent
but not teacher report. However, compared with siblings, children
with epilepsy were not reported to have a greater incidence of
difﬁculties on depression/anxiety domains, suggesting family
factors may play a role in the elevated levels of symptoms of
depression and anxiety in children with epilepsy.ample
ze
Measures Prevalence of depression/anxiety
01 Review of medical records
and interview about presence
of conditions
67 (13.4%) of children with epilepsy
met criteria for ‘Depression’, 6 (1%)
met criteria for ‘Bipolar Disorder’,
25 (5%) met criteria for ‘Anxiety’.
67 DAWBA and DSM-IV criteria 7 (16.7%) with ‘uncomplicated’
epilepsy and 4 (16%) of those with
‘complicated’ epilepsy met criteria
for an ‘Emotional Disorder’ compared
with 6.4% of those with diabetes
and 4.2% of the general paediatric
population.
34 Review of medical records
with respect to DSM-IV
criteria
16 (12%) of children with epilepsy
had a DSM-IV ‘Mood Disorder’.
11 BPI 29 (24%) of children with epilepsy
had signiﬁcant ‘Anxiety’ compared
with 16.5% of children with cardiac
difﬁculties and 7.5% of general
paediatric population
 DSM-IV, diagnostic and statistical manual of mental disorders fourth edition.21
rs later.
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speciﬁc or anxiety speciﬁc instruments and/or diagnostic inter-
views. Studies that have employed the Childhood Depression
Inventory28 have reported that between 12 and 32% of children
with epilepsy score in the at-risk range29–36 although the cut-offs
used to determine at-risk status have not always been the same in
clinic based studies. The highest reported rate by Tosun et al.31 was
for a group of adolescents with epilepsy who were selected as they
had low academic performance. With regard to other depression
speciﬁc instruments Roeder et al.37 reported that 36% of children
screened positive for symptoms of depression on the Short Mood
and Feelings Questionnaire (SMFQ).38 Turky et al.39 used the
Moods and Feelings Questionnaire (MFQ)40 and reported that
although 39.6% screened positive for depression on the MFQ based
on parent report, only 23.1% met criteria based on adolescent self-
report. Dunn et al.9 reported that only 9.6% of children and
adolescents met criteria for either dysthymia or major depression
on the Child Symptom Inventory (CSI)41 or Adolescent Symptom
Inventory.42 Rates of depression in children with epilepsy
employing DSM-IV diagnostic interviews in clinic based samples
have ranged from 12%7 to 36.5%.43 The highest rate of depression
reported by Thome-Souza et al.43 was for a clinic based study in
which the median IQ was 80 and 10 children had an IQ score below
55.
With regard to suicidal ideation Caplan et al.7 reported that 20%
of children with epilepsy had a rate of suicidal ideation in a clinic
based sample which was signiﬁcantly more than controls (9%) and
the 5.2% rate in the general population.44 Og˘uz et al.34 reported
that suicidal ideation was noted in 17.1% of children with epilepsy
and none of the control participants in a clinic based sample. It has
been suggested that bipolar disorders are rarely diagnosed in the
paediatric epilepsy population.45 Berg et al.23 reported that only 1%
of a population based sample of children with epilepsy had bipolar
disorder. Dunn et al.9 reported that 5.4% of 74 adolescents from a
clinic based sample screened in the at-risk range for bipolar
disorder on the ASI compared to only 0.9% of those in the
standardisation sample. However, no data for the prevalence of
bipolar disorder based on a diagnostic interview was reported on in
this study.
Compared with depression, anxiety disorders have not been as
frequently the focus of clinic based studies of children with
epilepsy. The instrument most commonly used in studies has been
the Revised Children’s Manifest Anxiety Scale (RCMAS).46 Loney
et al.30 reported that only one child of 22 children presenting with a
ﬁrst seizure exhibited a clinically signiﬁcant total anxiety score
(>2SD from the mean) on the RCMAS. However, eight of 22
children displayed ‘signiﬁcant’ symptoms of anxiety (>1SD from
the mean) in this study. Williams et al.47 reported that 23% of
children with epilepsy had scores higher than 1SD above the mean
and 5% had scores 2SD above the mean on the RCMAS. Using the
Kiddie Schedule for Affective Disorders and Schizophrenia (K-
SADS)48 diagnostic interview Jones et al.49 reported that 35.8% of
children experienced an anxiety disorder. Caplan et al.7 reported a
similar rate using the same instrument. The highest reported rate
of anxiety disorder in children with epilepsy (48.5%) was reported
in a study in Jordan by Alwash et al.50 who employed DSM-IV
criteria but did not employ standardised screening or diagnostic
measures. Adewuya and Ola51 reported a rate of 31.4% in a Nigerian
study using the Diagnostic Interview for Children Version IV (DISC-
IV).52
On screening instruments and diagnostic interviews children
with epilepsy have scored signiﬁcantly higher than con-
trols7,30,49,50 or had similar levels of anxiety to controls.32 Studies
of anxiety symptoms have not focussed on types of anxiety
disorder in epilepsy with the exception of Dunn et al.9 In this study
using the ASI/CSI, 1.8% of children with epilepsy met cut-off forgeneralized anxiety disorder, 34.9% for speciﬁc phobia, 34.9% for
obsessions, 8.9% for compulsions, 33.7% for postramatic stress
disorder, 1.9% for social phobia, and 6.0% for separation anxiety
disorder. In the 13–14-year-old group in this study 36.5% met
criteria for panic disorder. However, when the screening instru-
ment was followed by a diagnostic interview only 3% of those who
screened positive met criteria for PTSD, 50% who screened positive
met criteria for speciﬁc phobia, none met criteria for panic
disorder, 63% of screen positives met criteria for social/speciﬁc
phobia and 83% met criteria for obsessive–compulsive disorder.
This suggests that the screening instrument used in this study was
producing a signiﬁcant number of false positives and emphasises
the need for screening/surveillance to be followed up by diagnostic
interviews in studies reporting the prevalence of anxiety in
children with epilepsy.
4. Manifestation of depression and anxiety in epilepsy
An issue with regard to the reported rates of anxiety and
depressive symptoms in children with epilepsy concerns whether
symptoms of depression and anxiety are similar in children with
epilepsy to symptoms in children without epilepsy. In the case of
depression, Plioplys8 suggests that to date there is no research data
demonstrating that depression in young people with epilepsy is
characterised by a different phenomenology, clinical course or
treatment compared with depression in young people without
epilepsy. However, in a consensus statement on depression in
epilepsy Barry et al.53 emphasise that it is important to recognize
that although symptoms of depression and anxiety may be
common in children and adolescents with epilepsy, they may
not present with the ‘classic’ symptoms of these disorders.
Symptoms of depression associated with epilepsy may be
temporally related to the occurrence of seizures, either before a
seizure (preictally), as a clinical expression of the seizure (ictal),
following a seizure (postictally) or between seizures (interictal).
These symptoms are the least studied in a systematic manner and
are not often investigated by clinicians in evaluations of
individuals with epilepsy.53 According to Barry et al.53 these
symptoms would not be detected with the standard diagnostic
instruments and studies identifying the prevalence of depression
in epilepsy have not discriminated between an ictal, interictal,
preictal, or postictal occurrence. In a similar vein for symptoms of
anxiety, it has been suggested that it is useful to distinguish
between epilepsy-related preictal, ictal, postictal, and interictal
anxiety symptoms and ‘‘comorbid anxiety’’ which is unrelated to
epilepsy.13 Again anxiety symptoms of this nature remain under
researched in children and adolescents with epilepsy and none of
the population based studies or clinic based studies identiﬁed in
this review examined symptoms of depression or anxiety that are
temporally related to the occurrence of seizures. Another
consideration with regard to symptoms of depression and anxiety
in children with epilepsy concerns the effects of anti-epileptic drug
(AED) treatments. Most AEDs can cause symptoms of depression in
young people with epilepsy.54 If an AED with mood stabilising
properties is discontinued symptoms of a mood disorder which
was in remission due to effects of AED can return.54 The side effects
of AEDs might also include anxiety.55
5. The bidirectional nature of epilepsy and depression and
anxiety?
In children with epilepsy the relationship between seizures and
symptoms of depression and anxiety has increasingly been
addressed with regard to possible shared underlying mechanisms.
Kanner56 hypothesises that there is a bidirectional relationship
between mood disorders and epilepsy with seizures acting as a risk
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factor for the onset of epilepsy which may be explained by the
pathogenic mechanisms operant in both disorders. While people
with epilepsy are at greater risk of developing depressive disorders
there is also emerging evidence that individuals with depression
are at higher risk than the normal population of developing
epilepsy.57,58 With regard to onset of symptoms of anxiety/
depression, and onset of epilepsy Loney et al.30 reported that
children with a ﬁrst seizure had signiﬁcantly higher anxiety scores
compared with normative scores, and children with a ﬁrst seizure
also had signiﬁcantly higher scores than controls compared with
normative scores on a measure of depression. In a study by Jones
et al.49 24 (45.3%) children with epilepsy met diagnostic criteria for
a DSM-IV disorder before the diagnosis of epilepsy and ﬁrst
recognized seizures. Of these 24, eight had diagnosis of an anxiety
disorder and ﬁve met criteria for a depressive disorder. Hesdorffer
et al.58 reported that children and adults with incident unprovoked
seizure were 1.7 times more likely to have a history of major
depression before seizure onset. However, Austin et al.59 reported
that children with new onset epilepsy had signiﬁcantly higher
scores than sibling controls on some scales of the CBCL27 but not
the anxious/depressed scale, although the difference in scores on
the anxious/depressed scale approached signiﬁcance for a group of
children with previous seizures in this study. Therefore, it would
appear that a number of children who develop epilepsy have
signiﬁcant symptoms of depression and anxiety before seizure
onset although for other children with epilepsy, symptoms of
depression and/or anxiety develop after the onset of seizures. A
complicating factor in the temporal relationship between seizures
and symptoms of anxiety and depression concerns whether or not
seizures have been occurring before they are ﬁrst reported. It is
possible that seizures could be occurring during sleep, or during
waking without being identiﬁed as seizures but presenting as non-
compliance or low mood. It is also possible that abnormal EEG
activity without seizures has been occurring well before a ﬁrst
reported seizure. There is also the possibility that there is a primary
brain disorder of brain development that is causing both epilepsy
and depression.
6. Correlates of depression and anxiety in children and
adolescents with epilepsy
Correlates of depression and anxiety in childhood epilepsy have
been examined with respect to epilepsy/seizure correlates, AEDs,
child demographics, and child/family adaptation to epilepsy.
In terms of epilepsy/seizure correlates, variables that have been
focussed on include seizure type/epilepsy syndrome, seizure
frequency/severity, and age of seizure onset. Seizure type has
not been related to symptoms of anxiety or depression in most
studies.29,34,36,37,47 However, it has been reported that the
presence of seizure foci in the temporal lobe may represent a
higher risk for the development of depression and anxiety.43
Caplan et al.7 reported that there was a signiﬁcantly higher rate of
depression and combined depression and anxiety disorder in a
group of children with Complex Partial Seizures (CPS) compared
with a group of children with Childhood Absence Epilepsy (CAE),
but a higher rate of anxiety disorders in the CAE group. With regard
to seizure frequency/severity, Og˘uz et al.34 reported that increased
seizure frequency was associated with increases in anxiety and
depression scores and Turky et al.39 reported that poor seizure
control predicted higher depression scores. Adewuya and Ola51
reported than increased symptoms of anxiety were associated with
an increased frequency of seizures. Alwash et al.50 also reported
that symptoms of anxiety were higher when seizures were less
well controlled. However, Dunn et al.35 did not ﬁnd seizure
severity a signiﬁcant predictor of depressive symptoms andCusher-Weinstein et al.29 did not ﬁnd that frequency or severity
predicted scores on the CDI. Ettinger et al.36 did not ﬁnd that the
number of recent seizures was correlated with scores on
depression or anxiety measures. Age of seizure onset has not
been found to be a signiﬁcant predictor of anxiety or depression in
most studies of children with epilepsy.34–37 However, Cusher-
Weinstein et al.29 reported that scores on the interpersonal domain
of the CDI were signiﬁcantly correlated with younger age of onset.
Increased duration of epilepsy has not been associated with
symptoms of anxiety or depression36,37 although Cusher-Wein-
stein et al.29 reported that scores on the interpersonal domain of
the CDI were signiﬁcantly correlated with longer duration of
epilepsy.
In a review Ekinci et al.60 suggested that in most of the studies of
adolescents with epilepsy, AED use or type of AED have not been
found to be consistent predictors of depression. However, there
have been associations reported between some drugs and
symptoms of depression and anxiety in some young people with
epilepsy and also reported increases in such symptoms for children
or adolescents on more than one AED. Brent et al.61 reported an
association between phenobarbital and depression in children
with epilepsy although it was only reported in children with a
family history of depression. Anxiety and ‘nervousness’ have been
reported to be associated with drugs such as felbamate and
topirimate and with withdrawal of AEDs.62 Roeder et al.37 and
Adewuya and Ola51 reported that a greater number of AEDs was
the only variable that was independently predictive of more severe
symptoms of depression. Williams et al.47 noted that children with
epilepsy who were on polytherapy as opposed to monotherapy
were more likely to experience signiﬁcant anxiety symptoms.
Og˘uz et al.34 found that children with epilepsy who were receiving
more than one epileptic drug had higher anxiety and depression
scores compared to those were taking just one drug and Cusher-
Weinstein et al.29 reported that polytherapy was associated with
higher scores on the CDI. However, one study by Ettinger et al.36
reported that neither scores on a measure of depression or a
measure of anxiety differed based on whether the child was on
monotherapy or polytherapy.
In relation to child demographics, child age and gender have
been the two variables most frequently focussed on. Twice as many
female adults are depressed as male adults and this difference
tends to develop in early adolescence63 with girls having twice the
risk of developing depression than boys after puberty.64 Female
gender has been associated with higher mean depression scores in
some studies of children with epilepsy.39,65 However, gender
differences in studies of depressive symptoms have not been noted
in most studies of children with epilepsy.32,35,36,38 A study by
Buelow et al.33 suggests that level of IQ may play a role in
symptoms of depression in girls with epilepsy. This study found
while males tended to have more stable values across the IQ
groups, females displayed more variability. While 8% of females
with high IQ (101–130) in the study were deemed at risk on the CDI
the ﬁgure was 43% for those with low IQ (56–84). Despite the well-
known female predominance of anxiety in the general population
the predominance has not been widely reported in children with
epilepsy60 and a number of studies have not found a signiﬁcant
effect of gender on anxiety symptoms in children with epilep-
sy.31,36,47 However, McDermott et al.22 did report that male gender
was protective against having ‘anxiety’.
Symptoms of depression in younger children are less likely to
be present than symptoms in adolescents and studies which
employ measures of depression may exclude younger children
who would not be able to complete self-report measures of
symptoms. Thome-Souza et al.43 reported that the diagnosis of
depression was higher in a clinic referred group of children with
epilepsy who were aged 13–17 years compared with 7–12-year
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depression scores was 13.3% in a 9–11-year-old group and 40% in a
12–18-year-old group. However, some studies have not found age
to be a signiﬁcant predictor of depressive symptoms.26,34,35 It has
been suggested that older children with epilepsy are at risk for
higher levels of anxiety than younger children66 and signiﬁcant
differences in mean anxiety scores compared with controls were
more likely in an older group of children compared with a younger
cohort of children in a study by Og˘uz et al.30 However, increasing
age was not associated with an increase in the diagnosis of anxiety
disorders in the study of Adewuya and Ola.51
With regard to correlates of psychopathology in children with
epilepsy there has been an increasing emphasis on the possible
role of child and family adaptation to a diagnosis of epilepsy.
Epilepsy in adolescence is associated with signiﬁcant stigma67 and
Meador68 asserts that the perception patients have of their
condition affects their quality of life more than the condition
itself. Although there has been limited research on child attitudes
towards epilepsy and stigma it is likely that having epilepsy is
perceived by many as stressful. Dunn et al.35 reported that there
was an inﬂuence of child attitude towards having seizures and
satisfaction with family relationships on scores on a measure of
depression. In this study youths with epilepsy who had a negative
attitude towards having seizures and had a negative evaluation of
family relationships had signiﬁcantly higher rates of depressive
symptoms. Rodenburg et al.69 suggest that family related factors,
particularly quality of child parent relationship, and speciﬁcally
parental rejection are pivotal in psychopathology of children with
epilepsy. It is clear that having a child who develops epilepsy can
disrupt family functioning although it is not yet clear how
responses to the diagnosis of epilepsy among the affected child and
their parents impacts on symptoms of depression and anxiety in
affected children. With regard to parental depression, having a
child with epilepsy appears to be a risk factor for symptoms of
parental depression. Ferro and Speechley70 reviewed the literature
on depressive symptoms among mothers of children with epilepsy
and concluded that a relatively high proportion of mothers of
children with epilepsy display depressive symptoms, and that
available evidence suggest that a negative relationship exists
between such symptoms and child health outcomes. Cusher-
Weinstein et al.29 reported that parents of children with elevated
scores on the CDI reported signiﬁcantly higher scores in the
parental distress domain of the Parenting Stress Index. Adewuya
and Ola51 reported than higher child anxiety scores were
associated with higher scores on measures of family stressors,
perception of epilepsy stigma, parental psychopathology and
family stressors.
7. Symptoms of depression and anxiety in children with
epilepsy and intellectual disability
Approximately one quarter of children with epilepsy are
functioning in the intellectually disabled (ID) range (IQ < 70).71
The presence of intellectual disability in children is associated with
increased levels of psychopathology72 although psychiatric dis-
orders in children with intellectual disability may be under
recognized and under treated. The concept of ‘diagnostic over-
shadowing’,73–75 a phenomenon which highlights that clinicians
may emphasise a client’s intellectual disability and under
emphasise psychopathology76 has been proposed for this lack of
identiﬁcation and treatment. The assumption is that intervention
is not needed because the abnormal or atypical behaviour is an
inherent part of intellectual disability and may lead to disorders
being missed and untreated.77 However, there are difﬁculties in
diagnosing some disorders in an ID population and the criteria that
have been developed for people without intellectual disability maynot be as valid in children with ID.78 It is not clear if epilepsy and
intellectual disability combine to increase the risk of psychopa-
thology over and above that due to intellectual disability alone.
Steffenburg et al.18 reported on a population based study of
children with epilepsy and intellectual disability. Of the 90
children who were examined only 3% had ‘overanxious disorder’
as a main diagnosis and no rate was reported for mood disorders. It
must be noted that approximately one third of the children could
not be classiﬁed with respect to psychiatric disorder due to having
profound intellectual disability and no controls with intellectual
disability without epilepsy were used in the study. Using
population based data Lewis et al.19 did not ﬁnd that young
people with epilepsy and ID and young people with ID without
epilepsy differed signiﬁcantly with regard to the prevalence of
anxiety symptoms on the anxiety subscale of the Developmental
Behaviour Checklist.79 Assessing depressive symptoms in children
with epilepsy and intellectual disability may present signiﬁcant
assessment difﬁculties as on measures such as the CDI many
children with ID would struggle to read and as a result respond to
items.
8. Assessment and diagnosis of depression and anxiety in
children with epilepsy
Although published population based studies suggest that a
signiﬁcant minority of children with epilepsy are at risk for
clinically signiﬁcant symptoms of anxiety and depression the
identiﬁcation of such symptoms is not without challenges. The
clinical presentation of these symptoms in individuals with
epilepsy can create additional assessment challenges for clin-
icians.80 With regard to informants it is vital that where possible
children and adolescents are asked about symptoms, as given the
internalizing nature of symptoms of depression and anxiety
informants such as parents and teachers may not be aware of
depressive and anxiety symptoms the children are experienc-
ing.7,53 In paediatric patients in general, anxiety is usually more
difﬁcult to recognize than disorders with more overt clinical
symptoms and unless a child presents with symptoms of school
refusal, panic attack, or obsessive-compulsive symptoms, diagno-
sis is often delayed or missed.62 For children with signiﬁcant
cognitive deﬁcits there may be difﬁculties with regard to the ability
to verbalise thoughts and feelings thus making identiﬁcation of
signiﬁcant symptoms more problematic. In such cases parents and
other potential informants should be asked about signiﬁcant
recent changes in behaviour, sleep patterns, activity levels,
emotions, and patterns of social interaction. Taking a family
history of psychiatric disorders will also be important for all
children with epilepsy. A family history of depression was found to
be a signiﬁcant predictor of depression in children with epilepsy in
a clinic based sample43 and parental psychopathology was a
correlate of child symptoms in a another study.51 However, Caplan
et al.7 did not ﬁnd that family history was a signiﬁcant predictor of
affective or anxiety disorders.
The differential diagnosis of depression and anxiety in children
with epilepsy should include consideration of the effects of both
seizures and of AEDs.66 The occurrence of seizures can make it
difﬁcult to identify and isolate symptoms of anxiety. The fear of
seizures or seizure-related accidents may lead to symptoms
similar to agoraphobia and fear of having a seizure can be
associated with separation anxiety about being away from parents
or the home for children.60 The differential diagnosis of seizures
and panic disorder can also be difﬁcult,13 and panic attacks may
mimic complex partial seizures.66 Fear of embarrassment about
having a seizure in public may also lead to symptoms similar to
social phobia and result in withdrawal of the child from social
activities and interactions.13 It is important that a detailed history
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depression over time is garnered. Screening measures are designed
to over identify those at risk for a disorder and produce more false
positives than false negatives, and the use of anxiety speciﬁc and
depression speciﬁc checklists will need to be supplemented by
diagnostic interviews and comprehensive evaluation of symptoms
taking into account possible effects of seizures and AEDs.
9. Treatment of depression and anxiety in children with
epilepsy
The combination of cognitive behavioural therapy (CBT) and
medication has been found to be superior to medication alone for
the achievement of remission for paediatric depression,81,82 and
combination treatment appears to result in a more efﬁcacious
response than monotherapy in most, but not all studies.82,83 The
National Institute of Health and Clinical Excellence (NICE)
guideline for the treatment of depression in young people84 in
the UK, emphasises the importance of psychological therapies for
‘mild’ depression and psychological therapies in addition to
antidepressant medication for more ‘severe’ depression in young
people aged 12–18. Psychological therapies include group and
individual cognitive behavioural therapy (CBT), interpersonal
therapy and family therapy. The use of antidepressant medication
in those aged 12 or under should only be considered in very rare
circumstances according to the NICE guideline. It must be noted
that there are no references to epilepsy in the NICE guidelines. The
consensus statement on evaluation and treatment of people with
epilepsy and affective disorders53 emphasises that the treatment
of anxiety and depressive disorders in children requires the
expertise of mental health professionals, including a child
psychiatrist for psychopharmacological intervention, and a child
psychiatrist, psychologist, psychotherapist, or social worker for the
non-pharmacological treatments. Ekinci et al.60 suggest that the
treatment of depression in children with epilepsy should involve
pharmacotherapy accompanied by cognitive-behavioural
approaches as in the treatment of depression in children without
epilepsy. However, the evidence base for pharmacological or non-
pharmacological interventions in children with epilepsy is sparse.
There have been no double-blind studies on the psychopharmaco-
logical treatment of mood and anxiety disorders in youth with
epilepsy53 and children with epilepsy tend to be excluded from the
majority of drug studies.8 Regarding non-pharmacological inter-
ventions for symptoms of anxiety and depression in children with
epilepsy there has only been one published study of treatment
involving psychotherapy to prevent development of depression in
adolescents with epilepsy.85
Selective serotonin reuptake inhibitors (SSRIs) should be the
ﬁrst-line drugs in the treatment of depression and anxiety in
children with epilepsy8,53 due to their favourable side-effect
proﬁle, once a day administration, limited risk of fatal overdose,
and safe drug–drug interactions with AEDs.8 Tricyclic antidepres-
sants are not recommended for use in children with epilepsy
because of the potential increased seizure risk.53 Prior to initiating
psychopharmacological treatment for mood disorders in children
with epilepsy it is important to obtain a detailed history to
determine if the child’s mood symptoms reﬂect AED withdrawal,
high doses of AED polytherapy or use of AEDs with known
behavioural side effects.50 In the only study to report on the use of
SSRIs in children/adolescents with epilepsy Thome-Souza et al.86
reported on 36 children/adolescents with epilepsy diagnosed with
depression based on DSM-IV criteria. In 29 children/adolescents
sertraline was used and in the remaining seven children ﬂuoxetine
was prescribed. The authors reported that 35 of the 36 patients
responded positively in that there was total or partial remission of
depressive symptoms in the 12 months after introduction of theSSRI. Seizures were reported to have worsened in only two
individuals in the 3-month period after the SSRI was introduced.
All the children/adolescents in the study were functioning in the
non-intellectually disabled range, and none had other chronic
neurological disorders, metabolic or degenerative disorders or had
experienced psychogenic non-epileptic events.
Interventions for young people with epilepsy and depression or
anxiety may also involve psychotherapy. In the only published
study on psychotherapy for children with epilepsy Martinovic´
et al.85 reported on 30 adolescents (aged 13–19) with epilepsy who
met criteria for being at-risk for depression based on scores on a
diagnostic interview and checklists. The adolescents were ran-
domly assigned to short cognitive-behavioural interventions (CBI)
or treatment as usual (TAU). CBI consisted of an individual
treatment plan focussing on cognitive errors such as catastrophis-
ing, overgeneralization, personalisation, and selective abstraction.
CBI was administered once a week for eight weeks and then one
session per month over the next 4 months. TAU involved a similar
number of sessions and therapeutic counselling without CBI. Seven
to nine months after baselines three participants in the TAU group
and none of the CBI group participants had their ﬁrst depressive
episode (this difference was not statistically signiﬁcant). Follow up
also revealed that scores on checklists were signiﬁcantly lower in
the CBI compared with TAU group. The CBI group also had
signiﬁcantly higher quality of life scores at follow-up.
There has been no research on family therapy interventions for
children with epilepsy, although it has been recommended family
involvement should be a key treatment component for children
with mood disorders53 given the posited impact of epilepsy on
family functioning and hypothesised contributions of disruptions
in family functioning to child psychopathology. Supportive
individual or family therapy should address negative feelings
towards epilepsy in light of the high level of stigma associated with
the condition. Young people with active epilepsy are at signiﬁcant
risk for cognitive impairments,71 attention deﬁcit hyperactivity
disorder (ADHD),23 and autism spectrum disorder (ASD).87 These
may contribute directly or indirectly to depressive and anxiety
disorders and in terms of management it is important that
cognitive and behavioural impairments are identiﬁed and man-
aged through appropriate educational provision and psychological
and pharmacological interventions where necessary.
While there is now a well established link between epilepsy in
young people and depressive and anxiety disorders there are still
signiﬁcant barriers with regard to treatment. Roeder et al.37 reported
that despite identiﬁcation of signiﬁcant depressive symptoms
nearly two-thirds of parents of children with epilepsy did not seek
help for their child’s difﬁculties despite being advised to do so. They
suggested that mental-help seeking behaviours among this group
may differ from those found in the general population and it may be
that parents do not consider such symptoms to be a prime focus
being more concerned about seizure control. Another barrier to
intervention may be that because problems such as hyperactivity,
aggression, and impulsivity in children with epilepsy are more
noticeable and observable such difﬁculties are more likely to lead to
a psychological referral in comparison with the less obvious
symptoms of depression and anxiety. It would appear to be essential
that advice to parents and teachers of children with epilepsy should
always include reference to the risks for the development of
depression and anxiety disorders as well as reference to the common
symptoms of such disorders.
10. Conclusion
The literature on depression and anxiety in children and
adolescents with epilepsy was reviewed and available evidence
suggests that 12–14% of those with childhood epilepsy have
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population based evidence in relation to prevalence rates of
anxiety. There have been signiﬁcant variations in instruments used
to identify anxiety and depression and methods used to identify
those with epilepsy in published studies. For both anxiety and
depression the prevalence rates appear to be greater in young
people with epilepsy than in the normal paediatric population and
in children with other chronic medical conditions. The reason for
the increased rates remains unclear. There is a suggestion that
polytherapy may be associated with increased symptoms but no
clear risk factors emerge from an examination of seizures. In
relation to level of cognitive functioning it is not clear if subaverage
cognitive functioning or intellectual disability increases the risk for
the development of depression or anxiety.
The assessment and diagnosis of depression and anxiety in
children with epilepsy may not be straightforward with a
consideration of epilepsy variables and effects of AEDs being
necessary in any diagnostic formulation. There is a potential for
diagnostic confusion between panic attacks and complex partial
seizures. Treatment of depression and anxiety with psychological
therapies including CBT, and pharmacotherapy in children with
epilepsy have tended to follow similar lines to those of children
who do not have epilepsy and evidence about effective treatment
in childhood epilepsy is sparse. The value of delineation of the
cognitive and behavioural aspects of the phenotype and subse-
quent provision of appropriate educational social support have not
been examined as preventative measures of symptoms of
depression and anxiety in childhood epilepsy. On current evidence
there would appear to be a strong case for epilepsy services to
screen for depression and anxiety as part of a comprehensive
assessment of possible learning and behavioural/psychiatric co
morbidities. There is also a need for medical professionals working
in such settings to receive training on issues involved in
assessment, diagnosis and management and a need for research
into the efﬁcacy of such training with regard to the impact on
ameliorating symptoms of depression and anxiety and improving
quality of life in young people with epilepsy.
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